Clinical Trial Update: Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating a combination of irinotecan liposome with 5-fluorouracil, leucovorin, and bevacizumab for metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Avastin (bevacizumab)
• Leucovorin (folinic acid)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Colorectal Neoplasms Malignant | Phase 2 | Status: RECRUITING